Akebia Therapeutics | AKBA - 贸易债权人



金融业
股票价格
USD
资产
USD 362.52M
现金及等价物
USD 162.64M
销售成本
USD 10.34M
流动资产
USD 243.48M
流动负债
USD 173.88M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 27.38M
销售毛利
USD 47.28M
债务利息支出
362.52M
贷款资金
USD 36.4M
市值
USD 276.4M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13M
贸易债权人
USD 8.39M
应收帐款人
USD 47.03M


贸易债权人 更改 日
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amgen USD 19.52B 1.37B 2026-03
Ardelyx USD 28.2M 8.96M 2026-03
Astellas Pharma JPY 199.75B 17.8B 2026-03
AstraZeneca USD 22.89B 388M 2026-06
Bayer EUR 6.59B 496M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Celltrion KRW 88.58B 9.9B 2026-03
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Fresenius Medical Care EUR 890.43M 54.88M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
J&J USD 9.22B 1.24B 2026-06
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Moderna USD 167M 6M 2026-06
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 186K 23K 2025-06
Pharma Mar EUR 43.83M 10.51M 2026-03
Prothena USD 4.3M 1.58M 2026-03
PTC Therapeutics USD 40.45M 14.96M 2026-06
Qiagen NV USD 78.3M 5.64M 2026-03
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Sartorius EUR 329.1M 16.2M 2026-06
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03